Current pharmacotherapy of cryptosporidiosis: an update of the state-of-the-art

References

• Nime FA, Burek JD, Page DL, et al. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology. 1976;70(4):592–598.
   PubMed Web of Science ®Google Scholar
• Tandel J, English ED, Sateriale A, et al. Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum. Nat Microbiol. 2019;4(12):2226–2236. .
   PubMed Web of Science ®Google Scholar
• Khan A, Shaik JS, Grigg ME. Genomics and molecular epidemiology of Cryptosporidium species. Acta Trop. 2018;184:1–14.
   PubMed Web of Science ®Google Scholar
• Vanathy K, Parija SC, Mandal J, et al. Cryptosporidiosis: a mini review. Trop Parasitol. 2017;7:72–80.
   PubMedGoogle Scholar
• King BJ, Monis PT. Critical processes affecting Cryptosporidium oocyst survival in the environment. Parasitology. 2007;134(3):309–323.
   PubMedGoogle Scholar
• Ryan U, Hijjawi N, Xiao L. Foodborne cryptosporidiosis. Int J Parasitol. 2018;48(1):1–12.
   PubMed Web of Science ®Google Scholar
• Hellard M, Hocking J, Willis J, et al. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex Transm Infect. 2003;79(5):412–414.
   PubMed Web of Science ®Google Scholar
• Ravn P, Lundgren JD, Kjaeldgaard P, et al. Nosocomial outbreak of cryptosporidiosis in AIDS patients. BMJ. 1991;302(6771):277–280.
   PubMedGoogle Scholar
• Pandak N, Zeljka K, Cvitkovic A. A family outbreak of cryptosporidiosis: probable nosocomial infection and person-to-person transmission. Wien Klin Wochenschr. 2006;118(15–16):485–487.
   PubMed Web of Science ®Google Scholar
• Chalmers RM, Davies AP. Minireview: clinical cryptosporidiosis. Exp Parasitol. 2010;124(1):138–146.
   PubMed Web of Science ®Google Scholar
• Mor SM, Ascolillo LR, Nakato R, et al. Expectoration of Cryptosporidium parasites in sputum of human immunodeficiency Virus-Positive and -Negative adults. Am J Trop Med Hyg. 2018;98(4):1086–1090. .
   PubMed Web of Science ®Google Scholar
• Sponseller JK, Griffiths JK, Tzipori S. The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation. Clin Microbiol Rev. 2014;27(3):575–586.
   PubMed Web of Science ®Google Scholar
• Bouzid M, Hunter PR, Chalmers RM, et al. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013;26:115–134.
   PubMed Web of Science ®Google Scholar
• Ryan U, Fayer R, Xiao L. Cryptosporidium species in humans and animals: current understanding and research needs. Parasitology. 2014;141(13):1667–1685.
   PubMed Web of Science ®Google Scholar
• Khalil IA, Troeger C, Rao PC, et al., Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health. 6(7): e758–e768. 2018. .
   PubMed Web of Science ®Google Scholar
• Gatei W, Wamae CN, Mbae C, et al. Cryptosporidiosis: prevalence, genotype analysis, and symptoms associated with infections in children in Kenya. Am J Trop Med Hyg. 2006;75(1):78–82. .
   PubMed Web of Science ®Google Scholar
• Ryan U, Zahedi A, Paparini A. Cryptosporidium in humans and animals—a one health approach to prophylaxis. Parasite Immunol. 2016;38(9):535–547.
   PubMed Web of Science ®Google Scholar
• Alleyne L, Fitzhenry R, Mergen KA, et al. Epidemiology of Cryptosporidiosis, New York City, New York, USA, 1995-2018. Emerg Infect Dis. 2020;26(3):409–419. .
   PubMed Web of Science ®Google Scholar
• Ahmadpour E, Safarpour H, Xiao L, et al. Cryptosporidiose chez les patients VIH-séropositifs et facteurs de risque associés revue systématique et méta-analyse. Parasite. 2020;27:27.
   PubMedGoogle Scholar
• O’connor RM, Shaffie R, Kang G, et al. Cryptosporidiosis in patients with HIV/AIDS. AIDS. 2011;25(5):549–560.
   PubMed Web of Science ®Google Scholar
• Pielok L, Nowak S, Kłudkowska M, et al. Massive Cryptosporidium infections and chronic diarrhea in HIV-negative patients. Parasitol Res. 2019;118(6):1937–1942. .
   PubMed Web of Science ®Google Scholar
• Cacciò SM, Chalmers RM. Human cryptosporidiosis in Europe. Clin Microbiol Infect Dis. 2016;22(6):471–480.
   Google Scholar
• Robertson LJ, Temesgen TT, Tysnes KR, et al. An apple a day: an outbreak of cryptosporidiosis in Norway associated with self-pressed apple juice. Epidemiol Infect. 2019;147:e139.
   PubMed Web of Science ®Google Scholar
• Janssen B, Snowden J. Cryptosporidiosis. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Mor SM, Tumwine JK, Ndeezi G, et al. Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis. 2010;50(10):1366–1372.
   PubMed Web of Science ®Google Scholar
• Desai NT, Sarkar R, Cryptosporidiosis: KG. An under-recognized public health problem. Trop Parasitol. 2012;2(2):91–98.
   PubMedGoogle Scholar
• Khurana S, Chaudhary P. Laboratory diagnosis of cryptosporidiosis. Trop Parasitol. 2018;8(1):2–7.
   PubMedGoogle Scholar
• Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002;360(9343):1375–1380.
   PubMed Web of Science ®Google Scholar
• Rossignol JF, Ayoub A, Ayers MS. Treatment of Diarrhea caused by Cryptosporidium parvum: a prospective randomized, Double-Blind, Placebo-Controlled study of nitazoxanide. J Infect Dis. 2001;184(1):103–106.
   PubMed Web of Science ®Google Scholar
• Zhu G, Yin J, Cuny GD. Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis. Animal Dis. 2021;1(1):3.
   Google Scholar
• Wang B, Castellanos-Gonzalez A, White AC. Novel drug targets for treatment of cryptosporidiosis. Expert Opin Ther Targets. 2020;24(9):915–922.
   PubMed Web of Science ®Google Scholar
• Ashigbie PG, Shepherd S, Steiner KL, et al. Use-case scenarios for an anti-Cryptosporidium therapeutic. PLoS Negl Trop Dis. 2021;15(3):e0009057. .
   PubMed Web of Science ®Google Scholar
• Florescu DF, Sandkovsky U. Cryptosporidium infection in solid organ transplantation. World J Transpl. 2016;6:460–471.
   PubMedGoogle Scholar
• Sparks H, Nair G, Castellanos-Gonzalez A, et al. Treatment of Cryptosporidium: what we know, gaps, and the way forward. Curr Trop Med Rep. 2015;2(3):181–187.
   PubMedGoogle Scholar
• Anderson VR, Curran MP. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs. 2007;67(13):1947–1967.
   PubMed Web of Science ®Google Scholar
• Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005;40(8):1173–1180.
   PubMed Web of Science ®Google Scholar
• Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis. 2009;9(1):195.
   PubMed Web of Science ®Google Scholar
• ROMARK PHARMACEUTICALS. Alinia (nitazoxanide) tablets or oral suspension; 2016. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021818lbl.pdf [ Cited 2021 Apr 13th]
   Google Scholar
• Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):280–303.
   PubMedGoogle Scholar
• Samie A, Al-Qahtani A, El Bakri A, et al. Innovative strategies to interrupt cryptosporidium transmission in resource-Limited Settings. Curr Trop Med Rep. 2015;2(3):161–170.
   Google Scholar
• Chavez MA, White AC. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther. 2018;16(8):655–661.
   PubMed Web of Science ®Google Scholar
• Smith NH, Cron S, Valdez LM, et al. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998;178(3):900–903.
   PubMed Web of Science ®Google Scholar
• Bhadauria D, Goel A, Kaul A, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015;17(1):48–55. .
   PubMed Web of Science ®Google Scholar
• Sinkala E, Katubulushi M, Sianongo S, et al. In a trial of the use of miltefosine to treat HIV-related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality. Ann Trop Med Parasitol. 2011;105(2):129–134.
   PubMed Web of Science ®Google Scholar
• Love MS, Beasley FC, Jumani RS, et al. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis. 2017;11(2):e0005373. .
   PubMed Web of Science ®Google Scholar
• Iroh Tam PY, Arnold SLM, Barrett LK, et al. Clofazimine for treatment of cryptosporidiosis in HIV-infected adults (CRYPTOFAZ): an experimental medicine, randomized, double-blind, placebo-controlled phase 2a trial. Clin Infect Dis. 2020 Apr 11:ciaa421. Online ahead of print. doi: https://doi.org/10.1093/cid/ciaa421.
   Google Scholar
• Madbouly Taha N, Salah A, Yousof H-A, et al. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice. Exp Parasitol. 2017;181:57–69.
   PubMed Web of Science ®Google Scholar
• Choi R, Hulverson MA, Huang W, et al. Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned. Int J Parasitol. 2020;50(5):413–422.
   PubMed Web of Science ®Google Scholar
• Lunde CS, Stebbins EE, Jumani RS, et al. Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nat Comm. 2019;10(1):2816. .
   PubMed Web of Science ®Google Scholar
• Hulverson MA, Vinayak S, Choi R, et al., Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. J Infect Dis. 215(8): 1275–1284. 2017.
   PubMed Web of Science ®Google Scholar
• Huston CD. The CRYPTOFAZ trial and lessons learned for anticryptosporidial drug development. Clin Infect Dis. 2020 Apr 11:ciaa425 Online ahead of print. doi: https://doi.org/10.1093/cid/ciaa425.
   Google Scholar
• Diawara EH, François A, Stachulski AV, et al. Systemic efficacy on Cryptosporidium parvum infection of aminoxanide (RM-5061), a new amino-acid ester thiazolide prodrug of tizoxanide. Parasitology. 2021 Mar 29:1–10. Online ahead of print. doi: https://doi.org/10.1017/S0031182021000524
   Google Scholar
• Checkley W, White AC, Jaganath D, et al., A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 15(1): 85–94. 2015.
   PubMed Web of Science ®Google Scholar